International Business News - Biogen http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Biogen Idec Inc launched a hostile $355 million takeover bid for Facet Biotech Corp on Monday, two weeks after Facet's board rejected an identical offer. http://www.ibtimes.com/data/articleimgs/220880-.jpg http://www.ibtimes.com/articles/20090921/biogen-launches-hostile-355-mln-bid-facet.htm http://www.ibtimes.com/articles/20090921/biogen-launches-hostile-355-mln-bid-facet.htm Mon, 21 Sep 2009 10:54:45 EDT Biogen Idec Inc said on Tuesday it would be premature to conclude that the risk of developing a potentially deadly brain infection increases the longer patients take its multiple sclerosis drug Tysabri. http://www.ibtimes.com/data/articleimgs/220463-.jpg http://www.ibtimes.com/articles/20090915/biogen-says-pml-risk-factors-still-inconclusive.htm http://www.ibtimes.com/articles/20090915/biogen-says-pml-risk-factors-still-inconclusive.htm Tue, 15 Sep 2009 12:02:35 EDT Biogen Idec said on Friday it had offered to acquire Facet Biotech Corp, a partner in developing multiple sclerosis and cancer drugs, in a deal valued at about $355 million. http://www.ibtimes.com/articles/20090904/biogen-offers-buy-partner-facet-355-mln-deal.htm Fri, 04 Sep 2009 14:29:38 EDT